Pay in 4 interest-free payments of $6.63 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Neither NICE nor the MHRA has issued guidance recommending retatrutide, as it remains unlicensed
The content is not intended to encourage application, diagnosis, or self-treatment of unlicensed individuals, and should not be used as a substitute for the clinical judgment of a qualified healthcare provider.
Discount per Quantity Orders over $200 receive: FREE - USPS priority shipping Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Peptide Blend Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin peptide blend is a combination of peptides that may potentially interact with receptors in the pituitary gland
Referral to secondary care is indicated for severe or rapidly progressive neurological symptoms, diagnostic uncertainty, suspected bone marrow failure, or in pregnancy or paediatric cases
US$ 21.36
US$ 22.76
US$ 29.82
US$ 29.20